Exagen (XGN) Enterprise Value (2018 - 2025)
Exagen (XGN) has disclosed Enterprise Value for 8 consecutive years, with -$32.2 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 46.12% year-over-year to -$32.2 million, compared with a TTM value of -$32.2 million through Dec 2025, down 46.12%, and an annual FY2025 reading of -$32.2 million, down 46.12% over the prior year.
- Enterprise Value was -$32.2 million for Q4 2025 at Exagen, up from -$35.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11.2 million in Q1 2025 and bottomed at -$118.0 million in Q1 2021.
- Average Enterprise Value over 5 years is -$54.4 million, with a median of -$36.1 million recorded in 2023.
- The sharpest move saw Enterprise Value tumbled 76.73% in 2021, then surged 58.92% in 2025.
- Year by year, Enterprise Value stood at -$99.4 million in 2021, then surged by 37.26% to -$62.4 million in 2022, then surged by 41.51% to -$36.5 million in 2023, then surged by 39.62% to -$22.0 million in 2024, then crashed by 46.12% to -$32.2 million in 2025.
- Business Quant data shows Enterprise Value for XGN at -$32.2 million in Q4 2025, -$35.7 million in Q3 2025, and -$30.0 million in Q2 2025.